Impurity reference standards
Deferasirox impurities & reference standards
Characterised Deferasirox impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
35reference materials
1nitrosamine impurities
2isotope-labelled
COAHPLC · NMR · MS on request
2,2'-(1-Phenyl-1H-1,2,4-triazole-3,5-diyl)diphenol
- CAS
- 86245-87-6
- Formula
- C20H15N3O2
- MW
- 329.35 g/mol
VQ-047979
![2,2'-(Thiobis(2-hydroxy-5,1-phenylene))bis(4H-benzo[e][1,3]oxazin-4-one) chemical structure](/media/structures/IRPQJPVBYQOYLB-UHFFFAOYSA-N.svg)
2,2'-(Thiobis(2-hydroxy-5,1-phenylene))bis(4H-benzo[e][1,3]oxazin-4-one)
- CAS
- 1688656-86-1
- Formula
- C28H16N2O6S
- MW
- 508.5 g/mol
VQ-022321
4-Amino-3-((4-carboxyphenyl)diazenyl)benzoic Acid
- CAS
- 1914179-49-9
- Formula
- C14H11N3O4
- MW
- 285.25 g/mol
VQ-025229
Deferasirox Ferrate (III) Tripotassium Complex
- CAS
- 554445-58-8
- Formula
- C42H24FeN6O8-2
- MW
- 796.5 g/mol
VQ-047978
FAQs — Deferasirox impurities
Which Deferasirox impurities do you supply?
We list 35 Deferasirox-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Deferasirox impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Deferasirox impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Deferasirox impurity standards
We reply within one business day with price, pack options, lead time and documentation.